Nuance Files Patent Infringement Lawsuit Against M*Modal
Nuance Communications has filed a patent infringement lawsuit in the U.S. Federal District Court of Delaware against M*Modal. The lawsuit alleges that M*Modal's products violate six Nuance patents related to speech recognition, computer-assisted physician documentation, and transcription technology applied in the healthcare market.
This lawsuit is based on Nuance's U.S. Patent Nos. 9,564,126; 8,117,034; 7,379,946; 6,999,933; 6,766,295; and 6,308,158.
"Nuance has invested significant human and financial resources in developing innovations and building an intellectual property portfolio that are important components of our strategy and integral to the success of our business," said David Greenbaum, vice president of litigation and intellectual property at Nuance, in a statement. "Our IP and technology assets favorably differentiate our voice- and AI-powered offerings in the healthcare industry. We take great pride in and place significant value on our patents and will protect our rights."
In response to the lawsuit, M*Modal released the following statement:
"M*Modal is the market leader in physician-assistive speech and artificial intelligence technologies, experiencing rapid growth and adoption while earning numerous industry accolades. The company has a long history of bringing cutting-edge technology to market with numerous supporting patents. M*Modal believes Nuance's purported legal action over patents is utterly unfounded and creates unnecessary distraction in the healthcare industry. The company will keep its focus on what is truly important: creating time to care by driving innovative technology forward to physicians. M*Modal will continue to bring market-leading solutions to its clients, and this groundless matter will not impact the company's clients in any way as it will continue to be focused on allowing doctors to be doctors."